16:02 EDT Actuate Therapeutics (ACTU) files to sell 1.33M shares of common stock for holders
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACTU:
- Promising Clinical Developments and Valuation Support Buy Rating for Actuate Therapeutics
- Actuate Therapeutics announces end of Phase 1 portion of elraglusib study
- Actuate Therapeutics Secures $4.7M in Private Placement
- Actuate highlights results from subgroup analysis of Phase 2 elraglusib trial
- Actuate reports biomarker, machine learning data from Phase 2 elraglusib trial